Epidemiology of enteroaggregative Escherichia coli infections and associated outcomes in the MAL-ED birth cohort

PLoS Neglected Tropical Diseases

Volumn 11, Issue 7, 2017, Pages

  Rogawski, Elizabeth T ^a   Guerrant, Richard L ^a   Havt, Alexandre ^b   Lima, Ila F N ^b   Medeiros, Pedro H Q S ^b   Seidman, Jessica C ^c   McCormick, Benjamin J J ^c   Babji, Sudhir ^d   Hariraju, Dinesh ^d   Bodhidatta, Ladaporn ^e   Shrestha, Jasmin ^f   Anania, Japhat ^g   Maro, Athanasia ^g   Samie, Amidou ^h   Yori, Pablo Peñataro ⁱ   Qureshi, Shahida ^j   Mahfuz, Mustafa ^k   Bessong, Pascal O ^h   Kosek, Margaret N ^i,l   Ahmed, Tahmeed ^k   Bhutta, Zulfiqar A ^j   Lang, Dennis R ^c   Gottlieb, Michael ^c   Houpt, Eric R ^a   Lima, Aldo A M ^b   more..

^a UNIVERSITY OF VIRGINIA   (United States)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d CHRISTIAN MEDICAL COLLEGE   (India)

^e ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^f Walter Reed/AFRIMS Research Unit   (Nepal)

^g HAYDOM LUTHERAN HOSPITAL   (Tanzania)

^h UNIVERSITY OF VENDA   (South Africa)

ⁱ ASOCIACIÓN BENÉFICA PRISMA   (Peru)

^j AGA KHAN UNIVERSITY   (Pakistan)

^k INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^l JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; BIOLOGICAL MARKER; MACROLIDE; MYELOPEROXIDASE; NEOPTERIN; OROSOMUCOID;

AAIC GENE; AATA GENE; AGE; ARTICLE; BACTERIUM DETECTION; BREAST FEEDING; CAMPYLOBACTER; CHILD; CLINICAL OUTCOME; DATA ANALYSIS; DIARRHEA; DISEASE SURVEILLANCE; ENTERITIS; ENTEROAGGREGATIVE ESCHERICHIA COLI; ENTEROPATHY; ESCHERICHIA COLI INFECTION; FECES ANALYSIS; FEMALE; GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; RISK FACTOR; SOCIAL STATUS; AGE DISTRIBUTION; CHILD HEALTH; CLINICAL TRIAL; COHORT ANALYSIS; EPIDEMIC; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; INFANT; INTERNATIONAL COOPERATION; MICROBIOLOGY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NEWBORN; PATHOGENICITY; STATISTICAL MODEL; VIRULENCE;

AGE DISTRIBUTION; BIOMARKERS; CHILD HEALTH; COHORT STUDIES; DIARRHEA; DISEASE OUTBREAKS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERNATIONAL COOPERATION; LINEAR MODELS; MALE; MULTIVARIATE ANALYSIS; RISK FACTORS; VIRULENCE;

EID: 85026764944     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0005798     Document Type: Article

References (62)

1. Nataro JP, Kaper JB, Robins-Browne R, Prado V, Vial P, Levine MM, Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells. Pediatr Infect Dis J. 1987;6: 829–831. 3313248
2. Scavia G, Staffolani M, Fisichella S, Striano G, Colletta S, Ferri G, et al. Enteroaggregative Escherichia coli associated with a foodborne outbreak of gastroenteritis. J Med Microbiol. 2008;57: 1141–1146. doi: 10.1099/jmm.0.2008/001362-0 18719185
3. Cohen MB, Hawkins JA, Weckbach LS, Staneck JL, Levine MM, Heck JE, Colonization by enteroaggregative Escherichia coli in travelers with and without diarrhea. J Clin Microbiol. 1993;31: 351–353. 8432822
4. Adachi JA, Jiang ZD, Mathewson JJ, Verenkar MP, Thompson S, Martinez-Sandoval F, et al. Enteroaggregative Escherichia coli as a major etiologic agent in traveler’s diarrhea in 3 regions of the world. Clin Infect Dis Off Publ Infect Dis Soc Am. 2001;32: 1706–1709. doi: 10.1086/320756 11360211
5. Jiang Z-D, Greenberg D, Nataro JP, Steffen R, DuPont HL, Rate of occurrence and pathogenic effect of enteroaggregative Escherichia coli virulence factors in international travelers. J Clin Microbiol. 2002;40: 4185–4190. doi: 10.1128/JCM.40.11.4185-4190.2002 12409395
6. Wanke CA, Mayer H, Weber R, Zbinden R, Watson DA, Acheson D, Enteroaggregative Escherichia coli as a potential cause of diarrheal disease in adults infected with human immunodeficiency virus. J Infect Dis. 1998;178: 185–190. 9652439
7. Nataro JP, Mai V, Johnson J, Blackwelder WC, Heimer R, Tirrell S, et al. Diarrheagenic Escherichia coli infection in Baltimore, Maryland, and New Haven, Connecticut. Clin Infect Dis Off Publ Infect Dis Soc Am. 2006;43: 402–407. doi: 10.1086/505867 16838226
8. Nataro JP, Deng Y, Cookson S, Cravioto A, Savarino SJ, Guers LD, et al. Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteers. J Infect Dis. 1995;171: 465–468. 7844392
9. Mathewson JJ, Johnson PC, DuPont HL, Satterwhite TK, Winsor DK, Pathogenicity of enteroadherent Escherichia coli in adult volunteers. J Infect Dis. 1986;154: 524–527. 3525699
10. Huang DB, Nataro JP, DuPont HL, Kamat PP, Mhatre AD, Okhuysen PC, et al. Enteroaggregative Escherichia coli is a cause of acute diarrheal illness: a meta-analysis. Clin Infect Dis Off Publ Infect Dis Soc Am. 2006;43: 556–563. doi: 10.1086/505869 16886146
11. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet Lond Engl. 2013;382: 209–222. doi: 10.1016/S0140-6736(13)60844-2
12. Platts-Mills JA, Babji S, Bodhidatta L, Gratz J, Haque R, Havt A, et al. Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). Lancet Glob Health. 2015;3: e564–75. doi: 10.1016/S2214-109X(15)00151-5 26202075
13. Steiner TS, Lima AA, Nataro JP, Guerrant RL, Enteroaggregative Escherichia coli produce intestinal inflammation and growth impairment and cause interleukin-8 release from intestinal epithelial cells. J Infect Dis. 1998;177: 88–96. 9419174
14. Greenberg DE, Jiang Z- D, Steffen R, Verenker MP, DuPont HL, Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity. J Infect Dis. 2002;185: 944–949. doi: 10.1086/339617 11920319
15. Kaper JB, Nataro JP, Mobley HL, Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2: 123–140. doi: 10.1038/nrmicro818 15040260
16. Nataro JP, Kaper JB, Diarrheagenic Escherichia coli. Clin Microbiol Rev. 1998;11: 142–201. 9457432
17. Nataro JP, Yikang D, Yingkang D, Walker K, AggR, a transcriptional activator of aggregative adherence fimbria I expression in enteroaggregative Escherichia coli. J Bacteriol. 1994;176: 4691–4699. 7913930
18. Steiner TS, Nataro JP, Poteet-Smith CE, Smith JA, Guerrant RL, Enteroaggregative Escherichia coli expresses a novel flagellin that causes IL-8 release from intestinal epithelial cells. J Clin Invest. 2000;105: 1769–1777. doi: 10.1172/JCI8892 10862792
19. Harrington SM, Strauman MC, Abe CM, Nataro JP, Aggregative adherence fimbriae contribute to the inflammatory response of epithelial cells infected with enteroaggregative Escherichia coli. Cell Microbiol. 2005;7: 1565–1578. doi: 10.1111/j.1462-5822.2005.00588.x 16207244
20. Roche JK, Cabel A, Sevilleja J, Nataro J, Guerrant RL, Enteroaggregative Escherichia coli (EAEC) Impairs Growth while Malnutrition Worsens EAEC Infection: A Novel Murine Model of the Infection Malnutrition Cycle. J Infect Dis. 2010;202: 506–514. doi: 10.1086/654894 20594107
21. Bolick DT, Roche JK, Hontecillas R, Bassaganya-Riera J, Nataro JP, Guerrant RL, Enteroaggregative Escherichia coli strain in a novel weaned mouse model: exacerbation by malnutrition, biofilm as a virulence factor and treatment by nitazoxanide. J Med Microbiol. 2013;62: 896–905. doi: 10.1099/jmm.0.046300-0 23475903
22. Bolick DT, Kolling GL, Moore JH, de Oliveira LA, Tung K, Philipson C, et al. Zinc deficiency alters host response and pathogen virulence in a mouse model of enteroaggregative Escherichia coli-induced diarrhea. Gut Microbes. 2014;5: 618–627. doi: 10.4161/19490976.2014.969642 25483331
23. Rogawski ET, Guerrant RL, The burden of enteropathy and “subclinical” infections. Pediatr Clin North Am. 2017;In press.
24. GBD 2015 Mortality and Causes of Death CollaboratorsGlobal, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Lond Engl. 2016;388: 1459–1544. doi: 10.1016/S0140-6736(16)31012-1 27733281
25. de Onis M, Blössner M, Borghi E, Prevalence and trends of stunting among pre-school children, 1990–2020. Public Health Nutr. 2012;15: 142–148. doi: 10.1017/S1368980011001315 21752311
26. Dewey KG, Adu-Afarwuah S, Systematic review of the efficacy and effectiveness of complementary feeding interventions in developing countries. Matern Child Nutr. 2008;4Suppl 1: 24–85. doi: 10.1111/j.1740-8709.2007.00124.x 18289157
27. Nabwera HM, Fulford AJ, Moore SE, Prentice AM, Growth faltering in rural Gambian children after four decades of interventions: a retrospective cohort study. Lancet Glob Health. 2017;5: e208–e216. doi: 10.1016/S2214-109X(16)30355-2 28104187
28. Crane RJ, Berkley JA, Progress on growth faltering. Lancet Glob Health. 2017;5: e125–e126. doi: 10.1016/S2214-109X(16)30357-6 28104171
29. Cumming O, Cairncross S, Can water, sanitation and hygiene help eliminate stunting? Current evidence and policy implications. Matern Child Nutr. 2016;12Suppl 1: 91–105. doi: 10.1111/mcn.12258 27187910
30. MAL-ED Network InvestigatorsThe MAL-ED study: a multinational and multidisciplinary approach to understand the relationship between enteric pathogens, malnutrition, gut physiology, physical growth, cognitive development, and immune responses in infants and children up to 2 years of age in resource-poor environments. Clin Infect Dis Off Publ Infect Dis Soc Am. 2014;59Suppl 4: S193–206. doi: 10.1093/cid/ciu653 25305287
31. Richard SA, Barrett LJ, Guerrant RL, Checkley W, Miller MA, MAL-ED Network InvestigatorsDisease surveillance methods used in the 8-site MAL-ED cohort study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2014;59Suppl 4: S220–224. doi: 10.1093/cid/ciu435 25305290
32. Houpt E, Gratz J, Kosek M, Zaidi AKM, Qureshi S, Kang G, et al. Microbiologic methods utilized in the MAL-ED cohort study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2014;59Suppl 4: S225–232. doi: 10.1093/cid/ciu413 25305291
33. Kosek M, Guerrant RL, Kang G, Bhutta Z, Yori PP, Gratz J, et al. Assessment of environmental enteropathy in the MAL-ED cohort study: theoretical and analytic framework. Clin Infect Dis Off Publ Infect Dis Soc Am. 2014;59Suppl 4: S239–247. doi: 10.1093/cid/ciu457 25305293
34. World Health Organization and United Nations Children’s Fund Joint Monitoring Programme for Water Supply and Sanitation, (JMP). Progress on Drinking Water and Sanitation: Special Focus on Sanitation [Internet]. UNICEF, New York and WHO, Geneva; 2008. Available: http://www.wssinfo.org/fileadmin/user_upload/resources/1251794333-JMP_08_en.pdf
35. Psaki SR, Seidman JC, Miller M, Gottlieb M, Bhutta ZA, Ahmed T, et al. Measuring socioeconomic status in multicountry studies: results from the eight-country MAL-ED study. Popul Health Metr. 2014;12: 8. doi: 10.1186/1478-7954-12-8 24656134
36. Kosek MN, Lee GO, Guerrant RL, Haque R, Kang G, Ahmed T, et al. The MAL-ED study: Age and sex normalization of intestinal permeability for the assessment of enteropathy in infancy. J Pediatr Gastroenterol Nutr. 2017;In press.
37. World Health Organization. WHO Child Growth Standards: Length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age, Methods and development [Internet]. 2006. Available: http://www.who.int/childgrowth/standards/Technical_report.pdf?ua=1
38. Howe CJ, Cole SR, Westreich DJ, Greenland S, Napravnik S, Eron JJ, Splines for Trend Analysis and Continuous Confounder Control. Epidemiology. 2011;22: 874–875. doi: 10.1097/EDE.0b013e31823029dd 21968779
39. Zou G, A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159: 702–706. 15033648
40. Amour C, Gratz J, Mduma E, Svensen E, Rogawski ET, McGrath M, et al. Epidemiology and impact of Campylobacter infection in children in eight low-resource settings: results from the MAL-ED study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2016; doi: 10.1093/cid/ciw542 27501842
41. Kosek M, Ahmed T, Bhutta Z, Caulfield L, Guerrant R, Houpt E, et al. Causal Pathways from Enteropathogens to Environmental Enteropathy: Findings from the MAL-ED Birth Cohort Study. EBioMedicine. doi: 10.1016/j.ebiom.2017.02.024 28396264
42. Saiki T, Myeloperoxidase concentrations in the stool as a new parameter of inflammatory bowel disease. Kurume Med J. 1998;45: 69–73. 9658754
43. Rogawski ET, Platts-Mills JA, Seidman JC, John S, Mahfuz M, Ulak M, et al. Use of antibiotics in children younger than two years in eight countries: a prospective cohort study. Bull World Health Organ. 2017;95: 49–61. doi: 10.2471/BLT.16.176123 28053364
44. Mittal SK, Walker-Smith JA, McNeish AS, How protective is breast-feeding in diarrhoeal diseases? In: Diarrhoea and Malnutrition in Childhood. Boston: Butterworth & Co.; 1986. pp. 214–220.
45. Ambikapathi R, Kosek MN, Lee GO, Mahopo C, Patil CL, Maciel BL, et al. How multiple episodes of exclusive breastfeeding impact estimates of exclusive breastfeeding duration: report from the eight-site MAL-ED birth cohort study. Matern Child Nutr. 2016;12: 740–756. doi: 10.1111/mcn.12352 27500709
46. Yamamoto T, Echeverria P, Yokota T, Drug resistance and adherence to human intestines of enteroaggregative Escherichia coli. J Infect Dis. 1992;165: 744–749. 1552205
47. Gassama A, Aïdara-Kane A, Chainier D, Denis F, Ploy M-C, Integron-associated antibiotic resistance in enteroaggregative and enteroinvasive Escherichia coli. Microb Drug Resist Larchmt N. 2004;10: 27–30. doi: 10.1089/107662904323047763 15140390
48. Mendez Arancibia E, Pitart C, Ruiz J, Marco F, Gascón J, Vila J, Evolution of antimicrobial resistance in enteroaggregative Escherichia coli and enterotoxigenic Escherichia coli causing traveller’s diarrhoea. J Antimicrob Chemother. 2009;64: 343–347. doi: 10.1093/jac/dkp178 19474067
49. Okeke IN, Wallace-Gadsden F, Simons HR, Matthews N, Labar AS, Hwang J, et al. Multi-Locus Sequence Typing of Enteroaggregative Escherichia coli Isolates from Nigerian Children Uncovers Multiple Lineages. PLOS ONE. 2010;5: e14093. doi: 10.1371/journal.pone.0014093 21124856
50. Riddle MS, Gutierrez RL, Verdu EF, Porter CK, The chronic gastrointestinal consequences associated with Campylobacter. Curr Gastroenterol Rep. 2012;14: 395–405. doi: 10.1007/s11894-012-0278-0 22864805
51. Young KT, Davis LM, Dirita VJ, Campylobacter jejuni: molecular biology and pathogenesis. Nat Rev Microbiol. 2007;5: 665–679. doi: 10.1038/nrmicro1718 17703225
52. Bouckenooghe AR, Dupont HL, Jiang ZD, Adachi J, Mathewson JJ, Verenkar MP, et al. Markers of enteric inflammation in enteroaggregative Escherichia coli diarrhea in travelers. Am J Trop Med Hyg. 2000;62: 711–713. 11304060
53. Jiang Z-D, Okhuysen PC, Guo D-C, He R, King TM, DuPont HL, et al. Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. J Infect Dis. 2003;188: 506–511. doi: 10.1086/377102 12898436
54. Campbell DI, McPhail G, Lunn PG, Elia M, Jeffries DJ, Intestinal inflammation measured by fecal neopterin in Gambian children with enteropathy: association with growth failure, Giardia lamblia, and intestinal permeability. J Pediatr Gastroenterol Nutr. 2004;39: 153–157. 15269619
55. Guerrant RL, Leite AM, Pinkerton R, Medeiros PHQS, Cavalcante PA, DeBoer M, et al. Biomarkers of Environmental Enteropathy, Inflammation, Stunting, and Impaired Growth in Children in Northeast Brazil. PloS One. 2016;11: e0158772. doi: 10.1371/journal.pone.0158772 27690129
56. DeBoer MD, Scharf RJ, Leite AM, Férrer A, Havt A, Pinkerton R, et al. Systemic inflammation, growth factors, and linear growth in the setting of infection and malnutrition. Nutr Burbank Los Angel Cty Calif. 2017;33: 248–253. doi: 10.1016/j.nut.2016.06.013 27712965
57. Platts-Mills JA, Taniuchi M, Uddin J, Uddin Sobuz S, Mahfuz M, Gaffar SMA, et al. Association between enteropathogens and malnutrition in children aged 6–23 months in Bangladesh: a case-control study. Am J Clin Nutr. 2017;In press.
58. Jensen BH, Olsen KEP, Struve C, Krogfelt KA, Petersen AM, Epidemiology and Clinical Manifestations of Enteroaggregative Escherichia coli. Clin Microbiol Rev. 2014;27: 614–630. doi: 10.1128/CMR.00112-13 24982324
59. Taniuchi M, Walters CC, Gratz J, Maro A, Kumburu H, Serichantalergs O, et al. Development of a multiplex polymerase chain reaction assay for diarrheagenic Escherichia coli and Shigella spp. and its evaluation on colonies, culture broths, and stool. Diagn Microbiol Infect Dis. 2012;73: 121–128. doi: 10.1016/j.diagmicrobio.2012.03.008 22541788
60. Chattaway MA, Harris R, Jenkins C, Tam C, Coia JE, Gray J, et al. Investigating the link between the presence of enteroaggregative Escherichia coli and infectious intestinal disease in the United Kingdom, 1993 to 1996 and 2008 to 2009. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2013;18.
61. Boisen N, Scheutz F, Rasko DA, Redman JC, Persson S, Simon J, et al. Genomic Characterization of Enteroaggregative Escherichia coli From Children in Mali. J Infect Dis. 2012;205: 431–444. doi: 10.1093/infdis/jir757 22184729
62. Steiner TS, The worst of both worlds: examining the hypervirulence of the shigatoxigenic/enteroaggregative Escherichia coli O104:H4. J Infect Dis. 2014;210: 1860–1862. doi: 10.1093/infdis/jiu400 25038259